TaiGen Biopharmaceuticals Holdings Competitors and Similar CompaniesClear all

TaiGen Biopharmaceuticals Holdings's competitors and similar companies include Cipla and Mankind Pharma.

	TaiGen Biopharmaceuticals Holdings TaiGen Biopharmaceuticals Holdings (太景醫藥研發控股股份有限公司) is a company that focuses on the development of therapeutics for diseases such as cancer, infections, and diabetic complications.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.
Founding Date	Founding Date 2005	Founding Date 1935	Founding Date 1995
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Taipei, TW HQ	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations New Delhi, IN HQ
Employees	Employees 498% decrease	Employees 27,764	Employees 16,2532% increase
Financial
Revenue (est.)	Revenue (est.) NT$259.5m (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods NT$18.2m (FY, 2025)	Cost of goods ₹95.5b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit NT$242.8m (FY, 2025)	Gross profit ₹195b (FY, 2026)	Gross profit N/A
Net income	Net income NT$45.2m (FY, 2025)	Net income ₹38.7b (FY, 2026)	Net income N/A
Funding
Total funding raised	Total funding raised $ 75m	Total funding raised N/A	Total funding raised $ 239m